// App-Quantinova.ai

e18770 : Real-world clinical practice: Toxicities of maintenance PARP inhibitors in recurrent ovarian cancer—The Royal Marsden experience.

Researchers

Presenter

  • Zohra Ali

Principal Investigators

  • Laura Appadu

  • Ellen Kitetere

  • Julian Wampfler

  • Dorothy Yang

  • Philippa Jupp

  • Angela George

  • Susana N. Banerjee

Medical Centers

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Genetic Disorder

Disease

  • Gynaecological cancer

Biomarkers

  • N/A

Drug/Treatment

  • Bevacizumab

  • Rucaparib

  • Niraparib

  • Olaparib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved